Ledger.Open graph →
SEC Form D · filed November 12, 2021

Clade Therapeutics, Inc

Offering
$87.1M
Sold
$45.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Leandro A. Vetcher · Cambridge, MAExecMartin A. Murphy · Cambridge, MADirectorNeil A. White · Cambridge, MADirectorChad A. Cowan · Cambridge, MAExec · DirectorJim A. Glasheen · Cambridge, MAExec · DirectorDaniel A. Vasella · Cambridge, MADirectorYu Hu · Dedham, MADirectorJeffrey R. Theobald · Boston, MADirectorOppenheimer Jules Development Properties, LLC · Tulsa, OKDirectorSamantha Dale Strasser · Dedham, MAExec · DirectorReed J. Oppenheimer · Tulsa, OKExecOmri Amirav-Drory · Dedham, MAExec · DirectorBrian N. Clark · Tallahassee, FLExecPaul N. Woodward · Tallahassee, FLDirectorEric J. Wilkins · Charlotte, NCExec · DirectorStuart M. Christhilf Iv · Charlotte, NCDirectorMark Shaw · Menlo Park, CAExec · DirectorPhilip Summe · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗